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1. Introduction 
Ractopamine hydrochloride is a xenobiotic that belongs to a large group of ß2-adrenergic 
agonist compounds. ß2-Agonists are used in human and veterinary medicine for treatment 
of lung diseases as bronchodilators, tocolytics and heart tonics (Courtheyn et al., 2002; 
Malucelli et al., 1994; Meyer & Rinke, 1991). Besides their legal use, these drugs are often 
misused as growth promoters, to improve carcass composition by decreasing fat to the 
benefit of muscle mass, gaining higher economic benefit to producers (Anderson et al., 2009; 
Moody et al., 2000). Ractopamine hydrochloride increases the amount of lean meat and 
decreases the amount of carcass fat when fed to swine during the last 50 kg of gain, also 
increasing the rate of weight gain and feed conversion (Anderson et al., 1989; Merkel et al., 
1987; Watkins et al., 1990; Williams et al., 1994). The biochemical basis of ractopamine effects 
is increasing the nitrogen retention, protein synthesis, enhancing lipolysis and suppressing 
lipogenesis (Apple et al., 2007; Armstrong et al., 2004; Carr et al., 2005; Mills, 2002; Mitchell 
et al., 1990; Mitchell, 2009). 
Illegal use of ß2-agonists in 5- to 10-fold therapeutic doses leads to accumulation of these 
compounds in animal tissues such as liver, kidney and muscle (Smith, 1998; Smith & 
Shelver, 2002). High amounts of ß2-agonist residues in meat and meat products led to a 
number of cases of food poisoning in humans in the last 20 years (Brambilla et al. 1997; 
Garay et al., 1997; Martinez-Navarro, 1990; Pulce at al., 1991; Ramos et al., 2003), although 
the Council Directive 96/22/EC banned the use of these substances in the European Union. 
Consequently, detection of ß2-agonists in biological material from farm animals is a high 
priority because of the public health concern; relatively large numbers of samples have to be 
analyzed and more stringent criteria used in view of the serious public health implications 
of positive results. In order to provide quality assurance for the consumer and to satisfy 
legal testing obligations, the ability to detect drug residues at low concentrations has 
become a very important issue.  
Although all incidents of poisoning were caused by clenbuterol toxicity, the European 
Union has placed ban upon the use of all ǃ-agonists, thus requiring strict monitoring for the 
illegal use of this and other ǃ-agonists. Ractopamine was approved by the U.S. Food and 
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Drug Administration for use in finishing swine in 1999 (Anderson et al., 2009), whereas in 
European Union the use of ractopamine like other ǃ-agonists is completely banned. 
As ǃ-agonists are classified into group A substances having an anabolic effect and 
unauthorised substances, confirmation of the target analyte is necessary according to 
analytical performance criteria of the Commission Decision 2002/657/EC. As a result of the 
requirement of analytical criteria on confirmatory methods, mass spectrometry techniques 
are widely used to identify trace levels of organic residues and contaminants (Shao et al., 
2009). A number of methods, in most cases gas chromatography (GC) or liquid 
chromatography (LC) coupled with mass spectrometry (MS), are available for the analysis of 
ractopamine in a variety of matrices. On this, a minimum of four characteristic ions are 
required to satisfy the four identification points for the GC-MS or LC-MS techniques and 
one precursor ion and two daughter ions can provide four identification points for tandem 
mass spectrometry techniques including triple quadropole mass spectrometry and ion 
trapping techniques (e.g., LC-MS/MS and GC-MS/MS). Fragmentation pathway of 
ractopamine is shown in Figure 1. However, GC/MS methods require derivation because of 
their high polarity and low volatility, which is time-consuming, tedious, laborious and 
expensive (Shao et al., 2009). Because of its high sensitivity and selectivity, LC-MS/MS is 
often the method of choice in the analysis of trace levels of polar contaminants (Nielen et al., 
2008; Pleadin et al., 2011) and recently many authors demonstrated its superior performance 
in ractopamine analyses (Blanca et al., 2005; Churchwell et al., 2002). So far, ultra 
performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) is one of 
the most efficient methods (Nielen et al., 2008; Shao et al., 2009) because of the high 
resolution, rapid separation of UPLC, and the selectivity and sensitivity characteristic of MS-
MS detection (Dong et al., 2011; Zheng et al., 2010).  
Analysis of ractopamine residues is mostly performed in urine and plasma samples taken 
from living animals as well as in tissue samples after slaughtering (muscle, liver, kidney and 
fat) (Antignac et al., 2002; Gratacós-Cubarsí et al., 2006; Shao et al., 2009; Thompson et al., 
2008). Besides tissues and body fluids, hair has been shown to be an excellent site for 
accumulation of different drugs including ß-agonists and therefore also an appropriate 
matrix to monitor the presence of drug residues. Another advantage of hair as a matrix of 
choice to monitor the presence of ß-agonists is the ability to collect hair samples from living 
animals. On the other hand, there are little data on ractopamine accumulation in the hair of 
farm animals. Literature data show that in swine, ractopamine hydrochloride is very rapidly 
eliminated resulting in very low tissue residues, while major elimination route is via 
conjugation with glucuronic acid and urinary excretion (Dalidowicz, 1992).  
Bearing in mind rapid urinary excretion of ractopamine hydrochloride and hair affinity for 
ß2-agonist accumulation, the aim of this study was to determine ractopamine residues using 
UPLC-MS/MS and to compare residue levels of ractopamine hydrochloride in swine urine 
and hair samples after sub-chronic treatment with low ractopamine doses. 
2. Materials and methods 
2.1 Chemicals and apparatus 
Ractopamine hydrochloride (Sigma-Aldrich-Chemie, Steinheim, Germany) was used for 
animal treatment and method validation. Ractopamine-D5-hydrochloride (RIKILT, 
Wageningen, The Netherlands) was applied as internal standard. Protease Type XIV, from 
Streptomyces grisues (Sigma-Aldrich-Chemie, Steinheim, Germany) was used for hair sample 
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Fig. 1. Fragmentation pathway of ractopamine. 
analysis. ß-Glucuronidase/aryl sulfatase (Merck Chemicals, Darmstadt, Germany) was used 
for urine sample analysis. All solvents used were of HPLC grade. Screen Dau solid phase 
extraction columns (500 mg, 6 mL) used for clean up were from Amchro (Hattersheim, 
Germany). The analyses were performed on UPLC/MS/MS Xevo® TQ-S (Waters, En 
Yvelines Cedex, France). Hair samples were homogenized by means of a MM400 mixer mill 
(Retsch, Haan, Germany). Filtration and centrifugation of hair samples were performed on 
Amicon Ultra Centrifugal Filters Ultracell 10 K (Millipore, Carrigtwohill, Ireland). Hair 
samples were dried in a vacuum drying cabinet VT 6060 M (Heraeus, Hanau, Germany). 
2.2 Animals and sampling procedure 
The study included 12 male pigs (9 treated and 3 controls), Zegers hybrid type (white hair), 
55 kg body weight, farm-bred and kept under same conditions. Animals (n=9) were 
randomly divided into 3 groups and treated with ractopamine hydrochloride in a dose of 1 
mg daily (absolute) per os during 28 days (0.51 mg/kg b.w.). Treated animals were orally 
administered ractopamine hydrochloride in the form of a capsule filled with pure chemical 
admixed to feed. Three animals served as a control group and were left untreated. On days 
1, 3 and 8 after treatment withdrawal, treated animals were sacrificed in groups of 3. Control 
group animals were sacrificed on day 8 after experimental animal treatment withdrawal. 
Hair samples were obtained by shaving pigs with a razor blade and stored at room 
temperature. Urine samples after collection on slaughtering were stored at -20 °C until 
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analysis. All experiments were performed according to the Croatian Animal Protection Act 
(Official Gazette of the Republic of Croatia 135/06). 
2.3 Hair sample preparation and clean up 
Hair samples were washed with 2x20 mL of water and dried overnight. Dry hair was 
homogenized in mixer mill for 2x2 minutes and then mixed “head over head” for 60 
minutes. Internal standard of ractopamine-D5-hydrochloride (0.1 ng/μL), 5 mL of tris-buffer 
(pH=8) and 100 μL of protease solution (50 mg/mL in water) were added to the portion of 
500 mg of hair to obtain spiking level of 5 ng/g. The mixtures were incubated overnight at 
55 °C in shaker water bath. After incubation, 2 mL of phosphate buffer (pH=6) was added 
and pH was adjusted to 6. Samples were then shaken in ultrasonic bath at room temperature 
and centrifuged at 4 °C and 4000 rpm using Amicon filter units. The supernatants were 
transferred to another tube with addition of 200 μL of methanol, followed by centrifugation 
at 4 °C and 4000 rpm. The centrifuged extracts were loaded to SPE cartridges conditioned 
with 2 mL of methanol, 2 mL of water and 2 mL of phosphate buffer pH=6. Cartridges were 
washed with 1 mL of 1 M acetic acid and evaporated to dryness followed by washing with 2 
mL of methanol and evaporating to dryness. The elution was performed with 6 mL of 
mixture consisting of ethyl acetate and 25% ammonia at a 97:3 ratio. The samples were 
evaporated to dryness under stream of nitrogen at 35 °C. Residues were then dissolved in 
200 μL of HPLC mobile phase consisting of 0.1% formic acid in water (A)/0.1% formic acid 
in acetonitrile at a 95:5 ratio (B). 
2.4 Urine sample preparation and clean up 
A portion of 10 mL of urine was spiked with internal standard of ractopamine-D5-
hydrochloride (0.1 ng/μL) with addition of 5 mL of sodium acetate buffer (pH=5) and 50 μL 
of glucuronidase/aryl sulfatase to obtain spiking level of 5 ng/mL. The same steps were 
performed also without hydrolysis. The samples were shaken and incubated overnight at 37 
°C. After cooling at room temperature, 5 mL of phosphate buffer (pH=6) was added. The 
hydrolyzed solution was centrifuged followed by addition of 200 μL of methanol to 
obtained supernatants. The supernatants were loaded to SPE cartridges conditioned with 2 
mL of methanol, 2 mL of water and 2 mL of phosphate buffer (pH=6). Cartridges were then 
washed with 1 mL of 1 M acetic acid and evaporated to dryness followed by washing with 2 
mL of methanol and evaporating to dryness. The elution was performed with 6 mL of a 
mixture consisting of ethyl acetate and 25% ammonia at a 97:3 ratio. The samples were 
evaporated to dryness under stream of nitrogen at 35 °C. Residues were then dissolved in 
200 μL of HPLC mobile phase consisting of 0.1% formic acid in water (A)/0.1% formic 
acid(B) in acetonitrile at a 95:5 ratio.  
2.5 Liquid chromatography tandem mass spectrometry conditions 
The UPLC separation was performed on Acquity HSS C18 columns (150x2, 1.8 μm particle 
size) at a flow rate of 0.45 mL/min and temperature 40 °C. The mobile phase consisted of 
constituent A (0.1% formic acid in water) and constituent B (0.1% formic acid in acetonitrile). 
A gradient elution program was employed as follows: 0-5 min 95% A, 15 min 50% A, 17 min 
50% A, 18 min 10% A, 19 min 10% A, 20 min 95% A and 25 min 95% A. The injection volume 
was 10 μL. The mass spectrometry conditions were as follows: electrospray ionization, 
positive polarity, capillary voltage 0.65 kV, source temperature 150 °C, desolvation 
www.intechopen.com
Determination of Ractopamine Residues in Pigs by  
Ultra Performance Liquid Chromatography Tandem Mass Spectrometry  
 
335 
temperature 550 °C, cone gas 20 L/h, desolvation gas 1200 L/h, and collision gas 0.1 L/h. 
The mass spectrometer was operated in multiple reaction monitoring mode, the protonated 
molecular ion of ractopamine at m/z = 302.2 being the precursor ion. Four product ions at 
m/z = 284.2, m/z = 164.2, m/z = 121.2 and m/z = 107.1 were monitored. Quantitation was 
performed with most intensive transition (m/z 302.2 → 164.2) versus internal standard 
monitored (ractopamine-D5, m/z 307.1>167.1) and extrapolation using a six point 
calibration curves. 
2.6 Validation process 
Validation was carried out according to Commission Decision 2002/657/EC by an 
alternative approach of matrix comprehensive in-house validation by means of a factorial 
design software used for factorial design and calculation was InterVal Plus (quo data, 
Gesellschaft für Qualitätsmanagement und Statistik GmbH, Dresden, Germany). In 
validation process, decision limit (CCǂ), detection capability (CCǃ), precision, recovery, 
repeatability, in-house reproducibility, matrix effects, specificity and ruggedness were 
studied. Validation process started with factorial design for both matrices. Factors and their 
levels for hair and urine are presented in Table 1 and Table 3, respectively. 
 
Factor Level 
Species Calf / Cow 
Matrix condition White / Black 
Operator Analyst 1 / Analyst 2 
Storage of extracts (injection solution) 2 days, 4 °C  before injection/ without 
Instrument Xevo /Q-TOF 
Amount of matrix 200 mg / 500mg 
Table 1. Factors of interest and their levels used for validation of ractopamine in hair. 
For validation of ractopamine in hair, 16 runs, each for 5 concentration levels, were 
conducted within 16 days and with different factor combinations. In total, 80 measurements 
were performed. Table 2 shows experimental design for validation of the method of hair 
analysis as an example. 
Within each run, blank samples were fortified at five concentration levels: 2, 5, 8, 11 and 15 
ng/g. In addition, a matrix blank sample and reagent blank sample were included in each 
run.  
Validation for ractopamine in urine was preformed with 32 runs, 8 runs per species. Within 
each run, blank samples were fortified at six concentration levels: 0.125, 0.25, 0.375, 0.50, 
0.625 and 0.75 ng/mL. In addition, a matrix blank sample and reagent blank sample were 
included in each run. 
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   Factor level combination 
Run 
Sample 
Number 
Run name Species
Matrix 
cond. 
Operator 
Storage  
of extracts
Instrument 
Sample 
amount 
Run 15 P100260 AS100502 cow white Analyst 1 without Q-TOF 500 mg 
Run 02 P100262 AS100475 cow white Analyst 1 
2 days 
4 °C 
Xevo 200 mg 
Run 09 P100248 AS100496 calf black Analyst 1 without Xevo 200 mg 
Run 04 P100257 AS100477 cow black Analyst 1 without Xevo 500 mg 
Run 08 P100246 AS100481 calf black Analyst 1 
2 days 
4 °C 
Q-TOF 500 mg 
Run 10 P100247 AS100497 calf black Analyst 2 without Q-TOF 500 mg 
Run 11 P100250 AS100498 calf white Analyst 1 
2 days
4 °C
Xevo 500 mg 
Run 06 P100253 AS100479 calf white Analyst 1 without Q-TOF 200 mg 
Run 05 P100252 AS100478 calf white Analyst 2 without Xevo 500 mg 
Run 13 P100259 AS100500 cow black Analyst 1 
2 days
4 °C Q-TOF 200 mg 
Run 14 P100256 AS100501 cow black Analyst 2 
2 days
4 °C
Xevo 500 mg 
Run 07 P100249 AS100480 calf black Analyst 2 
2 days
4 °C
Xevo 200 mg 
Run 03 P100258 AS100476 cow black Analyst 2 without Q-TOF 200 mg 
Run 01 P100261 AS100474 cow white Analyst 2 
2 days
4 °C Q-TOF 500 mg 
Run 12 P100251 AS100499 calf white Analyst 2 
2 days
4 °C
Q-TOF 200 mg 
Run 16 P100263 AS100503 cow white Analyst 2 without Xevo 200 mg 
Table 2. Experimental plan for hair. 
 
Factor Level 
Species Bull / Calf / Cattle / Pig 
Ultrafiltration of injection solution Without / With 
Operator Analyst 1 / Analyst 2 
Storage of matrix before analysis 1 week at 4 °C / 1 week frozen 
SPE cartridges Small /Large 
Injection of final solutions Immediately / 2 days after finishing sample preparation,  if stored at 4 °C 
Enzyme Sigma / Merck 
Cartridges Starta X/ CSD 
Table 3. Factors of interest and their levels used for validation of ractopamine in urine. 
www.intechopen.com
Determination of Ractopamine Residues in Pigs by  
Ultra Performance Liquid Chromatography Tandem Mass Spectrometry  
 
337 
3. Results and discussion 
3.1 Applicability of study results 
There are literature reports on ractopamine determination using different techniques 
(Shelver & Smith, 2003; Smith et al., 1993; Thompson et al., 2008; Turberg et al., 1995). 
Studies suggest the use of LC/MS/MS systems as probably the best methods to improve 
sensitivity in determination of ǃ-adrenergic agonists, while retaining excellent selectivity 
(Smith & Shelver, 2002), pointing to UPLC-MS/MS as one of the most efficient methods.  
As the analysis of ractopamine in samples from all stages of production is important for 
monitoring illegal use in European Union, development of sensitive and selective 
methodologies in different matrices is required. Control and monitoring programs 
mandated by government have also necessitated implementation of assays for 
determination of ractopamine accumulation and excretion from tissues and body fluids in 
farm animals.  
Studies of ractopamine residue detection after different treatment schedules in different 
animal species have been reported by several authors (Elliot et al., 1998; Qiang et al., 2007; 
Smith & Shelver, 2002; Thompson et al., 2008). Published studies report on tissue residues of 
ractopamine and its urinary excretion (Antignac et al., 2002; Blanca et al., 2005; Dickson et 
al., 2005; Moragues & Igualada, 2009; Nielen et al., 2008; Thompson et al., 2008; Van Hoof et 
al., 2005) and ractopamine residues in hair (Nielen et al., 2008). However, there are little data 
on the accumulation of ractopamine in pig hair (white or black) as a novel matrix for the 
control of ractopamine illegal use. 
The aim of our study was to determine residue levels in swine urine (without and with 
sample hydrolysis) and hair samples after sub-chronic treatment of animals with 
ractopamine hydrochloride, using UPLC/MS/MS as a sensitive and reliable analytical 
method for determination of low ractopamine concentrations. Our study provided 
additional data on the ractopamine residue excretion and accumulation in swine. 
3.2 Method validation 
No interference on ractopamine identification was found owing to the highly specific MRM 
acquisition method and the use of an appropriate deuterated internal standard. The 
validation results for both analytical matrices are shown in Table 4 and Table 5. It is 
concluded that the methods showed relevant decision limit (CCǂ) and detection capability 
(CCǃ), with values 0.37 and 0.51 ng/g for urine and 2.53 and 2.98 ng/g for hair, 
respectively. The mean recoveries ranged from 93.9% to 94.6% for urine and from 103.0% to 
103.6% for hair. Also, the methods showed good repeatability, in-house reproducibility and 
linearity, and met the validation criteria set for quantitative residue analysis methods 
according to Decision. Successful validation of the method according to the European Union 
requirements and its application to real samples demonstrated its efficiency for veterinary 
control of ractopamine as a ǃ-agonist in hair and urine.  
 
Matrix Urine Hair 
CCǂ [ng/g] 0.37 2.53 
CCǃ [ng/g] 0.51 2.98 
Specificity passed passed 
Ruggedness passed passed 
Table 4. Validation results for ractopamine in urine and hair. 
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As part of the whole validation process the short time stability of ractopamine in urine and 
moreover the long-term stability was investigated. For that purpose a isochronic approach 
were applied (Lamberty 1998). The results are summarized in Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Short time and long-term stability of ractopamine in urine. 
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Matrix 
Spiked 
concentrat
ion 
(ng/mL) 
sr 
(ng/mL) 
RSD (%) 
sWR 
(ng/mL) 
RSD 
(%) 
Recovery 
(%) 
Urine 
0.125 0.008 6.1 0.045 35.8 93.9 
0.250 0.008 3.1 0.045 17.9 94.3 
0.375 0.011 3.0 0.062 16.6 94.5 
0.500 0.015 3.0 0.081 16.2 94.5 
0.625 0.019 3.0 0.100 16.0 94.6 
0.750 0.023 3.0 0.119 15.9 94.6 
Hair 
2.000 0.076 3.8 0.184 9.2 103.0 
5.000 0.190 3.8 0.374 7.5 103.4 
8.000 0.304 3.8 0.600 7.5 103.5 
11.00 0.418 3.8 0.837 7.6 103.5 
15.00 0.570 3.8 1.155 7.7 103.6 
Table 5. Repeatability, in-house reproducibility and recovery. 
3.3 Concentration of ractopamine residues 
3.3.1 Urine residues 
Ractopamine concentrations were determined in urine on days 1, 3 and 8 after 28 days of 
continuous treatment of pigs. The mean (±SD) ractopamine concentrations in urine samples 
without and with enzyme hydrolysis on days after treatment discontinuation in the 
experimental group of animals are shown in Table 6. 
 
Withdrawal 
time (days) 
Urine ractopamine concentrations (mean±SD, ng/mL) 
Without hydrolisis With hydrolisis 
1 
1.52±0.17 7.63±0.19 
0.29±0.03 4.47±0.04 
0.76±0.04 8.15±0.10 
3 
0.15±0.01 2.40±0.08 
0.47±0.08 6.32±0.15 
a a 
8 
0.38±0.01 6.53±0.12 
0.22±0.00 4.94±0.01 
a a 
a Insufficient urine obtained for analysis 
Table 6. Concentrations of ractopamine detected in urine by UPLC-MS/MS on days after 
withdrawal.  
As ß2-adrenergic agonist compounds are extensively metabolized to ǃ-glucuronide and/or 
sulfate conjugates in humans and animals, in the present study deconjugation was used as a 
second step on urine sample preparation. The ractopamine concentrations determined in 
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swine urine samples were much greater after ǃ-glucuronidase hydrolysis than those 
determined without this analytical step (Table 6). Figure 3 shows the UPLC-MRM 
chromatograms of confirmatory analysis of ractopamine in pig urine on days after 
withdrawal determined with hydrolysis. The concentration of ractopamine in urine samples 
processed with enzyme hydrolysis was almost 10-fold that recorded in urine samples 
analyzed without enzyme hydrolysis. Deconjugation step confirmed ractopamine to be 
excreted mainly in the form of glucuronide metabolites, as reported previously (Qiang et al., 
2007; Shelver & Smith, 2003). Therefore, further analyses (hair) were performed exclusively 
with sample hydrolysis and values obtained with sample enzyme hydrolysis were used on 
interpretation of the urine ractopamine concentrations. 
Earlier investigations performed in pigs with the use of a higher ractopamine anabolic dose 
(18 mg ractopamine hydrochloride/kg of feed) showed significantly higher concentrations 
of ractopamine in urine, with mostly twofold concentrations determined with sample 
enzyme hydrolysis (Qiang et al., 2007).  
Studies carried out in cattle and sheep report on detectable ractopamine residues in urine 5 
to 7 days after the last exposure to dietary ractopamine, pointing that hydrolysis of 
ractopamine metabolites may extend the period in which it is detected in cattle (Smith & 
Shelver, 2002). In their study, Thompson et al. (2008) fed pigs a feed containing 18 mg/kg 
ractopamine once daily for 10 days (180 mg of ractopamine in total). Ractopamine residues 
in pig urine were detectable by both screening and confirmatory methods until day 21 of 
treatment withdrawal. Urine sample analyses showed high concentrations of ractopamine 
ranging from 473.6 ng/mL to 1131.6 ng/mL on day 1 of withdrawal period. After seven 
days, the concentration of ractopamine was considerably lower, ranging from 3.4 ng/mL to 
6.2 ng/mL. In our study, which was also performed in pigs but with a dose approximately 6 
times lower (28 mg of ractopamine in total), the mean ractopamine residues in urine ranged 
from 6.7±1.8 ng/mL on day 1 of withdrawal to 5.7±0.9 ng/mL on the last day of 
withdrawal. Our study indicated that in spite of rapid urinary excretion, ractopamine 
residues can be detected in urine samples eight days after treatment cessation. Elliott et al. 
(1998) report ractopamine depletion in calves; their study showed the  high concentration of 
ractopamine detected on day 1 of withdrawal (280 ng/mL) to be followed by a decline to the 
level of 18 ng/mL (day 3 of withdrawal), and no ractopamine residue detectable on day 14. 
In calf, the ractopamine residue concentrations found after drug withdrawal were also 
substantially lower than during the medication period, and were only detectable in one 
animal 2 weeks after removal of medication from the diet (Elliot et al., 1998). In their study 
on cattle treated with 20 mg/kg dietary ractopamine for seven days, Smith and Shelver 
(2002) obtained similar results concerning rapid urinary excretion of ractopamine. 
Ractopamine residues were 2523±1367 ng/mL on day 1 of withdrawal and on day 6 residue 
levels were below the limit of quantification. This study was simultaneously, in the same 
conditions and treatment schedule, conducted in sheep. Results obtained by analyzing 
sheep urine samples were rather different. The concentration of ractopamine in urine 
samples after 7 days of withdrawal was still detectable, 178±78 ng/mL (Smith & Shelver, 
2002). These results indicate that urinary excretion of ractopamine is species dependent, 
meaning that even with similar doses, different animal species excrete ractopamine in 
different time frames. Literature data indicate that swine eliminate nearly 85% of the 
ractopamine administered during the first day, resulting in relatively low tissue residues 
(Dalidowicz et al, 1992). In comparison with some literature data (Qiang et al., 2007; Smith & 
Shelver, 2002), low concentrations of ractopamine urinary residues determined in our study 
could be explained by low exposure of animals to ractopamine.  
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Fig. 3. UPLC-MRM chromatograms of confirmatory analysis of ractopamine in pig urine: 
(A) urine reagent blank; (B) urine matrix blank; (C) urine sample of treated animal on day 1 
after withdrawal; (D) urine sample of treated animal on day 8 after withdrawal; (E) blank 
urine sample spiked with 0.1 µg/kg ractopamine and 0.5 µg/kg ractopamine-d5. 
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3.3.2 Hair residues 
On days 1, 3 and 8 after 28 days of continuous treatment of pigs, ractopamine concentrations 
were determined in hair (white) samples. The mean (±SD) ractopamine concentrations in 
hair on days after treatment discontinuation in the experimental group of animals are 
shown in Table 7. In spite of the low ractopamine dose administered to pigs in our study, 
residues were determined in hair with the UPLC-MS/MS method, showing its selectivity 
and sensitivity, i.e. applicability in the control of ractopamine illegal use using hair as a 
matrix. Chromatograms of the UPLC-MS/MS method of confirmatory analysis of 
ractopamine in pig hair on days after withdrawal are shown in Figure 4. 
 
Withdrawal time 
(days) 
Hair ractopamine concentrations  
(mean±SD, ng/g) 
1 
9.34±1.58 
13.31±0.16 
13.72±0.68 
3 
11.06±0.21 
13.7±0.45 
9.8±0.41 
8 
9.95±0.05 
8.65±0.95 
7.70±0.10 
Table 7. Concentrations of ractopamine detected in hair by UPLC-MS/MS on days after 
withdrawal. 
In our study, the mean concentrations of ractopamine determined in hair samples were 
12.12±2.42 ng/g on day 1 after withdrawal, 11.52±1.99 ng/g on day 3 and 8.77±1.13 ng/g on 
the last day after withdrawal. Analyses of hair samples showed the concentrations of 
ractopamine on the same days of withdrawal to be significantly higher in hair samples than 
in urine. The hair/urine concentration ratios on days 1, 3 and 8 of withdrawal were 1.8, 2.6 
and 1.5, respectively. Radeck and Gowik (2010) conducted a study on non-lactating cows 
treated with 6 different ß2-agonists, including ractopamine in a dose of 1500 mg overall. 
That study revealed the concentration of ractopamine on days after withdrawal to be higher 
in urine samples than in hair samples, both white and black. Results of our study performed 
on pigs indicated the concentration of ractopamine on days after withdrawal to be higher in 
white hair samples than in urine samples. This discordance of results can be interpreted 
with regard to different experimental animal species, the dose of ractopamine used and 
different ractopamine application schemes employed. Bearing in mind the scarce data on 
ractopamine residues in swine hair, both black and white, there is a need to perform another 
study that would include swine with black hair in order to yield data on ractopamine 
residues in both hair types. Also, a long-term depletion study of ractopamine on swine 
would be useful to determine maximum withdrawal time with detectable residues in hair 
samples. 
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Fig. 4. UPLC-MRM chromatograms of confirmatory analysis of ractopamine in pig hair: (A) 
hair reagent blank; (B) hair matrix blank; (C) hair sample of treated animal on day 1 after 
withdrawal; (D) hair sample of treated animal on day 8 after withdrawal. 
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4. Conclusion 
A validated UPLC-MS/MS method was employed for determination of ractopamine in pig 
urine and hair at trace levels. The method features were found to be fit-for-purpose, with 
successful method validation according to the European Union requirements and its 
suitability for determination of low ractopamine residues in real samples. Study results 
indicated that the excretion of ractopamine in pig urine and accumulation in hair could 
clearly point to its abuse in pigs as food producing animals, in particular when using sample 
hydrolysis with ǃ-glucuronidase on ractopamine determination, which extended the period 
in which ractopamine could be detected. Results of our study indicated the concentration of 
ractopamine on days after withdrawal to be higher in white hair samples than in urine 
samples. 
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